Categories Earnings, Technology

Earnings preview: What to expect from Disney’s Q2 results?

The Walt Disney Company (NYSE: DIS) is scheduled to report its second quarter 2019 earnings results on Wednesday, May 8, after market close. Analysts expect earnings to decline 13.6% to $1.59 per share while revenues are expected to drop 1% to $14.4 billion. Looking at the past four quarters, the company has topped earnings estimates in three of them.

The second quarter had some major highlights. Disney completed the acquisition of 21st Century Fox’s assets and in the process became the majority stakeholder in the streaming service Hulu. Disney also announced that it would launch its own streaming service, Disney +, in the US on November 12 this year.

This acquisition has provided Disney with a rich trove of content and a massive advantage in the marketplace. Updates on Disney’s strategy and progress with regards to these assets is an area to keep an eye on. Another area of strength is ESPN+ with its rapidly expanding subscriber base and updates on this space are also key.

Disney has been making significant investments in its business units and these could lead to higher revenues in the Parks segment. Although the Studio segment is likely to benefit from the hit movie Captain Marvel, it might not match the performance of the Black Panther which released at the same time last year.

The higher investments are also likely to lead to higher costs that could in turn weigh on the bottom line results for the second quarter. Overall, Disney might not disappoint with its second quarter results.

In the first quarter, Disney topped market estimates for revenue and earnings. Revenues of $15.3 billion were flat with the year-ago quarter while adjusted EPS declined 3% to $1.84.

Disney’s shares have gained 25% so far this year.

 

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top